Trial · NCT05966129
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| 10 Day Silverman Integrated Analgesic Assessment (SIA) Score | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 1.4 | Standard Deviation 95.9 | score on a scale | |
| 10 Day Silverman Integrated Analgesic Assessment (SIA) Score | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | -1.4 | Standard Deviation 93.1 | score on a scale | |
| 10 Day Pain Intensity as Measured by the PROMIS Numeric Pain Rating Scale | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 5.2 | Standard Deviation 2.2 | score on a scale | |
| 10 Day Pain Intensity as Measured by the PROMIS Numeric Pain Rating Scale | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 5.1 | Standard Deviation 2.3 | score on a scale | |
| Post-surgery Opioid Usage, Measured in Milligrams of Morphine Equivalents (MME) Per Day | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 10.0 | Inter-Quartile Range 3.0 to 20.0 | MME/day | |
| Post-surgery Opioid Usage, Measured in Milligrams of Morphine Equivalents (MME) Per Day | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 8.9 | Inter-Quartile Range 3.5 to 18.4 | MME/day | |
| 3 Month Prescription Pain Medication Misuse | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 38.5 | Standard Deviation 3.8 | T-score | |
| 3 Month Prescription Pain Medication Misuse | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 39.2 | Standard Deviation 4.5 | T-score | |
| 1 Month PROMIS Mobility Score | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 40.4 | Standard Deviation 16.6 | score on a scale | |
| 1 Month PROMIS Mobility Score | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 39.4 | Standard Deviation 17.2 | score on a scale | |
| Number of Participants With Opioid Persistence | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 24 | Participants | ||
| Number of Participants With Opioid Persistence | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 21 | Participants | ||
| Participants With Drug-Gene Concordance | Acute Pain - Immediate PGx Testing (Modified Intent-to-treat, mITT) | 112 | Participants | ||
| Participants With Drug-Gene Concordance | Acute Pain - Delayed PGx Testing (Modified Intent-to-treat, mITT) | 47 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05966129/results